Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Nephrolithiasis, Protein urine
Clinical narrative: Kidney stone that was blocking his urinal/kidney stone before the shot but not as severe; This spontaneous case was reported by a consumer and describes the occurrence of NEPHROLITHIASIS (Kidney stone that was blocking his urinal/kidney stone before the shot but not as severe) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Kidney stone.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEPHROLITHIASIS (Kidney stone that was blocking his urinal/kidney stone before the shot but not as severe) (seriousness criterion medically significant). At the time of the report, NEPHROLITHIASIS (Kidney stone that was blocking his urinal/kidney stone before the shot but not as severe) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: abnormal (abnormal) Discovered Patient had kidney stone that was blocking his urinal.. On an unknown date, Protein urine: abnormal (abnormal) protein in his urine..         Concomitant product use was not provided by the reporter.   No treatment information was provided.  Patient stated that 21 days after the 2nd dose he had severe pain in the pelvic area. He went to the emergency room, they did CAT scan and discovered he had kidney stone that was blocking his urinal. He had kidney stone before the shot but not as severe. There was also protein in his urine.  Company comment: This is a spontaneous case concerning a male patient of unknown age, with a history of Nephrolithiasis, who experienced the serious (due to medically important condition) unexpected, event of Nephrolithiasis after the second dose of mRNA-1273 vaccine. The patient reported severe pelvic pain 21 days after vaccination, went to the emergency department, where a tomography was performed showing a kidney stone and urine analysis with proteinuria. The patient had kidney stones before vaccination although not as severe, suggestive of exacerbation of pre-existing condition. The mentioned medical history remains as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-476114 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a male patient of unknown age, with a history of Nephrolithiasis, who experienced the serious (due to medically important condition) unexpected, event of Nephrolithiasis after the second dose of mRNA-1273 vaccine. The patient reported severe pelvic pain 21 days after vaccination, went to the emergency department, where a tomography was performed showing a kidney stone and urine analysis with proteinuria. The patient had kidney stones before vaccination although not as severe, suggestive of exacerbation of pre-existing condition. The mentioned medical history remains as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.